CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business CombinationBusiness Wire • 09/07/21
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care DiagnosticsBusiness Wire • 08/20/21
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contact the FirmPRNewsWire • 04/29/21
Diagnostics company LumiraDX to go public via merger with SPAC in deal valued at about $5 billionMarket Watch • 04/07/21
LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition CorpBusiness Wire • 04/07/21